Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 22 Feb 2008
At a glance
- Drugs Atazanavir; Lamivudine/zidovudine; Lopinavir/ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms LORAN
- 22 Feb 2008 New trial record.
- 03 Feb 2008 24-week efficacy results have been presented (15th Conference on Retroviruses and Opportunistic Infections : abstr. 780).